|
End-of-day quote
Shanghai S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 4.930 CNY | -1.79% |
|
-2.57% | -3.71% |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,919 | 24,052 | 26,691 | 25,148 | 25,531 | 24,583 | - | - |
| Change | - | -10.65% | 10.97% | -5.78% | 1.52% | -3.71% | - | - |
| Enterprise Value (EV) 1 | 29,021 | 21,882 | 24,319 | 20,414 | 20,954 | 20,458 | 19,818 | 20,287 |
| Change | - | -24.6% | 11.14% | -16.06% | 2.65% | -2.37% | -3.13% | 2.37% |
| P/E | 11.6x | 12.2x | 12.7x | 10.2x | 11.6x | 10.8x | 9.94x | 8.98x |
| PBR | 1.31x | 1.09x | 1.14x | 0.95x | 0.96x | 0.83x | 0.8x | 0.76x |
| PEG | - | -0.8x | 1.76x | 0.6x | -1x | 2.7x | 1.18x | 0.8x |
| Capitalization / Revenue | 0.22x | 0.17x | 0.18x | 0.17x | 0.16x | 0.14x | 0.13x | 0.13x |
| EV / Revenue | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x |
| EV / EBITDA | 6.93x | 6.21x | 6.5x | 4.61x | 5.18x | 4.28x | 3.67x | 3.34x |
| EV / EBIT | 8.08x | 7.67x | 8.05x | 5.62x | 6.34x | 5.82x | 5.18x | 4.75x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2 | 0.203 | 0.219 | 0.248 |
| Rate of return | 2.04% | 3.83% | 3.57% | 3.91% | 3.91% | 4.12% | 4.44% | 5.03% |
| EPS 2 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.44 | 0.4576 | 0.4961 | 0.5489 |
| Distribution rate | 23.6% | 46.7% | 45.5% | 40% | 45.5% | 44.4% | 44.2% | 45.2% |
| Net sales 1 | 122,407 | 140,424 | 150,140 | 151,810 | 161,390 | 171,813 | 182,137 | 192,315 |
| EBITDA 1 | 4,187 | 3,526 | 3,741 | 4,427 | 4,046 | 4,777 | 5,398 | 6,073 |
| EBIT 1 | 3,593 | 2,853 | 3,023 | 3,635 | 3,306 | 3,513 | 3,824 | 4,274 |
| Net income 1 | 2,448 | 2,085 | 2,174 | 2,507 | 2,255 | 2,300 | 2,507 | 2,762 |
| Net Debt 1 | 2,102 | -2,170 | -2,372 | -4,734 | -4,576 | -4,125 | -4,765 | -4,296 |
| Reference price 2 | 5.470 | 4.846 | 5.434 | 5.120 | 5.120 | 4.930 | 4.930 | 4.930 |
| Nbr of stocks (in thousands) | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | 4,986,434 | - | - |
| Announcement Date | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | 4/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 10.97x | 0.12x | 4.38x | 4.04% | 3.74B | ||
| 35.8x | 12.9x | 27.02x | 0.55% | 1,116B | ||
| 37.07x | 6.25x | 17.38x | 2.11% | 610B | ||
| 36.17x | 8.31x | 17.13x | 2.45% | 501B | ||
| 112.15x | 5.92x | 25.35x | 2.35% | 358B | ||
| 20.49x | 5x | 12.4x | 2.64% | 366B | ||
| 21.24x | 5.55x | 13.66x | 2.88% | 288B | ||
| 22x | 4.43x | 12.71x | 1.99% | 261B | ||
| 27.56x | 7.08x | 12.68x | 2.32% | 235B | ||
| -45.98x | 7.04x | 27.26x | 2.1% | 195B | ||
| Average | 27.75x | 6.26x | 17.00x | 2.34% | 393.35B | |
| Weighted average by Cap. | 35.02x | 8.16x | 19.96x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions
















